A Message from the Director
Professor, Department of Medicine
Professor, Department of Molecular Pharmacology
Judy R. & Alfred A. Rosenberg Professional Chair in Diabetes Research
Director, Diabetes Research Center, Department of Medicine
I would like to share with you some exciting new developments in the Albert Einstein College of Medicine Diabetes Research Center.
As part of our on going Diabetes Research mission I am pleased to announce that we have formally developed a partnership with the Icahn School of Medicine at Mount Sinai. This new regional center, renamed The Einstein-Mount Sinai Diabetes Research Center ES-DRC, will allow for increased research collaborations at both the basic, translational and clinical levels for both type 1 and type 2 diabetes initiatives. In addition, we have expanded our faculty research base to over 120 independent laboratories through out the New York Metropolitan area that include faculty from New York University, Weill Cornell Medical College, Cornell University, Winthrop University Hospital, Stony Brook University and Hunter College.
We are also particularly excited about our increased capacity for human pancreatic beta cell regeneration/replication research with the establishment of a new Human Islet and Adenovirus Biomedical Research Core facility housed at Mount Sinai. This, coupled with our new Translational Research Core at Einstein, will provide the needed infrastructure to efficiently bring basic laboratory findings into the realm of human clinical investigative studies.
To support new initiatives in diabetes and related metabolism research, the ES-DRC has initiated two grant funding programs. The Pilot & Feasibility Research grant program is primarily focused on new investigators or established investigators outside the diabetes research field that have novel approaches for understanding, intervention and/or treatment of diabetes. We have also initiated a new Microgrant program that supports use of the ES-DRC Core facilities for investigators to develop new concepts and obtain preliminary data for extramural grant submissions. With the current difficult climate of funding at the national level, these internal resources will ensure the continued high productivity and accomplishments of our diabetes center investigators that are making important inroads to our understanding and treatment of this prevalent and complex disease.